Skip Header
Important information: The value of investments can go down as well as up so you may get back less than you invest. Investors should note that the views expressed may no longer be current and may have already been acted upon. This is a third-party news feed and may not reflect Fidelity’s views.

OptiBiotix launches SlimBiome products on Amazon India

(Sharecast News) - OptiBiotix Health announced the launch of multiple SlimBiome-containing products under its GoFigure brand on Amazon India on Monday, marking a strategic expansion into the country's rapidly growing weight management market. The AIM-traded firm said the initiative was part of its broader multi-channel strategy aimed at increasing product sales through both online and in-store channels.

India, now the world's most populous nation, was projected to have the largest cohort of medium- to high-income consumers by 2035.

With obesity prevalence currently at 40.3%, the board said the market presented significant opportunities for weight management solutions.

OptiBiotix said its wholly-owned OptiBiotix India subsidiary would sell GoFigure products via Amazon, in addition to their existing presence in Apollo Pharmacies and on Apollo's e-commerce platform.

The launch on Amazon India coincided with a rebranding of the product's packaging and a relaunch in Apollo pharmacies.

OptiBiotix said the new design featured more vibrant colours to enhance visibility, and included prominent branding of Tata's Fossence, a locally-recognised ingredient aimed to enhance consumer trust and familiarity.

The GoFigure range is manufactured in India using local suppliers, incorporating Tata's proprietary Fossence prebiotic ingredient.

"Launching products on Amazon India is another step forward in building a presence for the Company's products in the strategically important Indian market," said chief executive officer Stephen O'Hara.

"We are now building SlimBiome's presence across India via our own brand products through Amazon India and via Apollo pharmacies, and as private label partnerships following the recent launch by Dr Morepen.

"This initial launch will include four products with subsequent launches taking place throughout 2025 dependent on sales progress."

At 1515 GMT, shares in OptiBiotix Health were up 5.41% at 17.92p.

Reporting by Josh White for Sharecast.com.

Share this article

Related Sharecast Articles

Berenberg raises target price on Warpaint London
(Sharecast News) - Analysts at Berenberg slightly raised their target price on cosmetics firm Warpaint London from 680.0p to 700.0p on Monday, noting the group's margin management was not to be overlooked.
UK Oil & Gas reports increase in production at Horndean
(Sharecast News) - UK Oil & Gas reported a significant increase in production at the Horndean oil field on Monday, following a successful workover campaign in late 2024.
Unilever nearing £230m deal to buy refillable cosmetics maker Wild - report
(Sharecast News) - Consumer goods giant Unilever is reportedly closing in on a £230m deal to snap up Wild, a premium producer of refillable personal care products backed by the founders of Innocent Drinks.
Light Science Tech secures distribution deal with Gavita International
(Sharecast News) - Light Science Technologies announced on Monday that it has secured a distribution framework agreement with Gavita International, granting it exclusive rights to sell Agrolux Nederland's horticultural LED lighting systems in the UK and Ireland.

Important information: This information is not a personal recommendation for any particular investment. If you are unsure about the suitability of an investment you should speak to one of Fidelity’s advisers or an authorised financial adviser of your choice. When you are thinking about investing in shares, it’s generally a good idea to consider holding them alongside other investments in a diversified portfolio of assets. Past performance is not a reliable indicator of future returns.

Award-winning online share dealing

Search, compare and select from thousands of shares.

Expert insights into investing your money

Our team of experts explore the world of share dealing.